0001354488-16-007428.txt : 20160513 0001354488-16-007428.hdr.sgml : 20160513 20160513171627 ACCESSION NUMBER: 0001354488-16-007428 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 28 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160513 DATE AS OF CHANGE: 20160513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Green Planet Bio Engineering Co. Ltd. CENTRAL INDEX KEY: 0001392449 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 371532842 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-52622 FILM NUMBER: 161649535 BUSINESS ADDRESS: STREET 1: 18851 NE 29TH AVENUE STREET 2: SUITE 700 CITY: AVENTURA STATE: FL ZIP: 33180 BUSINESS PHONE: 212 930 9700 MAIL ADDRESS: STREET 1: 18851 NE 29TH AVENUE STREET 2: SUITE 700 CITY: AVENTURA STATE: FL ZIP: 33180 FORMER COMPANY: FORMER CONFORMED NAME: Mondo Acquisition II, Inc. DATE OF NAME CHANGE: 20070308 10-Q 1 gplb_10q.htm QUARTERLY REPORT gplb_10q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_______________________

FORM 10-Q
_______________________
(Mark One)
 
x
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2016

or
 
¨
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from___________ to ____________
      
Commission file number 000-52622

GREEN PLANET BIOENGINEERING CO., LTD.
(Exact Name of Registrant as Specified in its charter)
 
Delaware   37-1532842
(State or other jurisdiction of incorporation or organization)    (I.R.S. EmployerIdentification No.)
 
20807 Biscayne Blvd., Suite 203,
Aventura, Florida
  33180
 (Address of principal executive offices)   (Zip Code)
 
(305) 328-8662
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ¨    No ¨

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer
 o
Accelerated filer
 o
Non-accelerated filer
 o
Smaller reporting company
 x
(Do not check if a smaller company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes x  No  ¨
 
The number of shares of common stock outstanding as of May 13, 2016 was 20,006,402.
 
 
 

 
 
TABLE OF CONTENTS
 
PART I   FINANCIAL INFORMATION Page
       
 
4
       
    Condensed Balance Sheets as of March 31, 2016 (Unaudited) and December 31, 2015
4
       
    Condensed Statements of Operations for the Three Months Ended March 31, 2016 and 2015 5
       
    6
       
    7
       
 
9
       
 
10
       
 
10
 
 
   
PART II   OTHER INFORMATION  
       
 
11
       
 
11
       
 
11
       
 
11
       
 
11
       
 
11
       
  SIGNATURES 12
 
 
 
2

 
 
INTERIM FINANCIAL STATEMENTS

The unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions under Regulation S-X of the Securities and Exchange Commission (“SEC”) Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2015.

The financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.


 FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934.  These statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses.  Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes,” “may,” “will,” “should,” “could,” “plans,” “estimates,” and similar language or negative of such terms.  Our actual results may differ significantly from those projected in the forward-looking statements.  Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  Although we believe that the expectations reflected in the forward-looking statements are reasonable, we do not know whether we can achieve positive future results, levels of activity, performance, or goals.  Actual events or results may differ materially.  We undertake no obligation to publicly release any revisions to the   forward-looking statements or reflect events or circumstances taking place after the date of this document.
 
 
 
3

 
 
PART I
FINANCIAL INFORMATION

FINANCIAL STATEMENTS
 
Condensed Balance Sheets
 
   
March 31,
   
December 31,
 
   
2016
   
2015
 
   
(Unaudited)
       
ASSETS
           
Current assets            
Cash and cash equivalents   $ -     $ -  
TOTAL CURRENT ASSETS / TOTAL ASSETS
  $ -     $ -  
LIABILITIES AND STOCKHOLDERS’ DEFICIT
               
LIABILITIES
               
Current liabilities                
Accounts payable   $ -     $ -  
Accrued liabilities   $ 6,450     $ 11,450  
Amount due to a related party   $ 147,303     $ 136,311  
TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES
  $ 153,753     $ 147,761  
STOCKHOLDERS’ DEFICIT
               
Preferred stock: par value of $0.001 per share                
Authorized: 10,000,000 shares at March 31, 2016 and December 31, 2015                
Issued and outstanding: 0 shares at March 31, 2016 and December 31, 2015     -       -  
Common stock: par value of $0.001 per share                
Authorized: 250,000,000 shares at March 31, 2016 and December 31, 2015          
Issued and outstanding: 20,006,402 shares at March 31, 2016 and                
31-Dec-15   $ 20,006     $ 20,006  
Additional paid-in-capital   $ 609,614     $ 609,614  
Accumulated deficit
  $ (783,373 )   $ (777,381 )
TOTAL STOCKOLDERS’ DEFICIT
  $ (153,753 )   $ (147,761 )
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
  $ -     $ -  
 
See Notes to the Condensed Financial Statements
 
 
 
4

 
 
Condensed Statements of Operations
(Unaudited)
 
   
Three months ended March 31,
 
   
2016
   
2015
 
Administrative expenses
  $ (5,992 )   $ (5,027 )
Loss before income taxes
  $ (5,992 )   $ (5,027 )
Provision for income taxes
    -       -  
Net loss
  $ (5,992 )   $ (5,027 )
                 
Earnings per share
               
Basic and diluted
  $ *     $ *  
Weighted average number of shares outstanding
               
Basic and diluted
  $ 20,006,402     $ 20,006,402  
 
* Less than $.01, per share
 
See Notes to the Condensed Financial Statements
 
 
5

 
 
 Condensed Statements of Cash Flows
 (Unaudited)
 
   
Three months ended March 31,
 
   
2016
   
2015
 
Cash flows from operating activities
           
Net loss   $ (5,992 )   $ (5,027 )
Changes in operating assets and liabilities:                
Accounts payable     -     $ 490  
Accrued liabilities   $ (5,000 )   $ (5,574 )
Amount due to a related party
  $ 10,992     $ 10,111  
Net cash flows used by operating activities
    -       -  
                 
Cash flows from investing activities
    -       -  
                 
Cash flows from financing activities
    -       -  
                 
Net decrease in cash and cash equivalents
    -       -  
Cash and cash equivalents – beginning of period
    -       -  
Cash and cash equivalents – end of period
  $ -     $ -  
Supplemental disclosures for cash flow information:
               
Cash paid for interest   $ -     $ -  
Cash paid for income taxes   $ -     $ -  
 
See Notes to the Condensed Financial Statements
 
 
6

 
 
Notes to the Condensed Financial Statements
(Unaudited)

1. General Information

Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name to Green Planet Bioengineering Co., Ltd. (“Company”) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries which was subsequently divested to One Bio, Corp (“ONE”) on April 14, 2010.

In March 2012, the Company became a subsidiary of Global Fund Holdings Corp. (“Global Funds”) an Ontario, Canada Corporation.

The Company operates as a public organized shell corporation with the purpose to acquire or merge with an existing business operation.  The Company's activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

2. Summary of significant accounting policies

Basis of Presentation
 
The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.

Use of Estimates
 
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported.  Actual results could differ from those estimates.  Significant items that require estimates were accruals of liabilities.

Cash and cash equivalents
 
Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.

Earnings per share
 
Earnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures.  Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive.  Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share.

Fair Value Measurements
 
FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investment measured and reported at fair value are classified and disclosed in one of the following hierarchy:

Level 1  -  Quoted prices are available in active markets for identical investments as of the period reporting date.
Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.
 
 
7

 
 
2. Summary of Significant Accounting Policies – continued

Level 3 - Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment.  The inputs into the determination of fair value require significant management judgment or estimation.
 
Recent Changes in Accounting Standards
 
A variety of proposed or otherwise potential accounting standards are currently under study by standard-setting organizations and various regulatory agencies. Because of the tentative and preliminary nature of these proposed standards, management has not determined whether implementation of such proposed standards would be material to the Company’s financial statements.
 
3. Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from Global Funds, the majority stockholder.
 
4. Amount Due to a Related Company

The Company relies on a related company to advance funds to finance its operating expenses.  The amounts advanced are interest-free, unsecured and are repayable upon demand.
 
5. Preferred stock / Common stock

Preferred stock
 
The Company is authorized under its Articles of Incorporation to issue 10,000,000 shares of Series A preferred stock with a par value of $0.001 per share. Each share of the Company’s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company’s common stock. The preferred stock is non-participating and carries no dividend.

Common stock
 
The Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001 per share. During the three months ended March 31, 2016, the Company did not issue any shares of common stock or warrants.

6. Stock-based compensation

There was no non-cash stock-based compensation recognized for the three months ended March 31, 2016 and 2015.
 
 
8

 


General Overview

The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation.

Results of Operations and Financial Condition for the three months ended March 31, 2016, as compared to the three months ended March 31, 2015

The Company had no active business operations for the periods ended March 31, 2016 and March 31, 2015. Expenses consist of accounting and filing fees.

Liquidity and capital resources

The Company had no active business operations for the three months ended March 31, 2016. Accordingly, the Company had no liquidity and capital resources for the period.

Risk factors

The Company’s critical accounting policies are still being applied despite that the Company has no ongoing business operations.

Significant Estimates

Critical accounting polices include the areas where we have made what we considered to be particularly subjective or complex judgments in making estimates and where these estimates can significantly impact our financial results under different assumptions and conditions.

We prepare our financial statements in conformity with generally accepted accounting principles in the United States of America. As such, we are required to make certain estimates, judgments and assumptions that we believe are reasonable based upon the information available. These estimates, judgments and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could be different than those estimates.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Market Risks

There has been no material change in market risks since our last Annual Report on Form 10-K for the year ended December 31, 2015.
 
 
9

 

 
Not Applicable
 
 
Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of the fiscal period end, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
 
 
10

 
 
PART IIOTHER INFORMATION


None


None


None



None


31         Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of theSarbanes-Oxley Act of 2002
 
32         Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section1350
 
 
11

 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned; thereunto duly authorized this 13th day of May, 2016.

 
  GREEN PLANET BIOENGINEERING CO., LTD.  
       
Date: May 13, 2016
By:
/s/ Jordan Weingarten  
    Jordan Weingarten  
    President and Chief Financial Officer  
   
(Principal Executive Officer and Principal Financial Officer)
 

 
12

 
EX-31 2 gplb_ex31.htm CERTIFICATION gplb_ex31.htm
Exhibit 31
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
 
I, Jordan Weingarten, certify that:
 
 
1.    I have reviewed this quarterly report on Form 10-Q of Green Planet Bioengineering Co., Ltd.;

 
2.    Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 
3.    Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 
4.    I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
 
b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
 
c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures and evaluated the effectiveness of our internal control over financial reporting, and presented in this report my conclusions about the effectiveness of our internal control over financial reporting, as of the end of the period covered by this report based on such evaluation;

 
d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
 
 
5.   I have disclosed, based on my most recent evaluation, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
 
 
a)
all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 
b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
 

       
Date: May 13, 2016
By:
/s/ Jordan Weingarten  
    Jordan Weingarten  
    President and Chief Financial Officer  
   
(Principal Executive Officer and Principal Financial Officer)
 
EX-32 3 gplb_ex32.htm CERTIFICATION gplb_ex32.htm
Exhibit 32
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Green Planet Bioengineering Co. Limited (the “Company”) on Form 10-Q for the period ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mr. Jordan Weingarten, President and CFO of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

(1)                   The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of1934; and

(2)                   The information contained in the Report fairly presents, in all material respects, the financial condition andresults of operations of the Company.
 
       
Date: May 13, 2016
By:
/s/ Jordan Weingarten  
    Jordan Weingarten  
    President and Chief Financial Officer  
   
(Principal Executive Officer and Principal Financial Officer)
 
EX-101.INS 4 gplb-20160331.xml 0001392449 2016-01-01 2016-03-31 0001392449 2016-03-31 0001392449 2015-12-31 0001392449 2015-01-01 2015-03-31 0001392449 2014-12-31 0001392449 2015-03-31 0001392449 2016-05-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Green Planet Bio Engineering Co. Ltd. 0001392449 10-Q 2016-03-31 false --12-31 No No Yes Smaller Reporting Company Q1 2016 .001 .001 10000000 10000000 .001 .001 250000000 250000000 Delaware 2006-10-30 20006402 0 0 0 0 0 0 0 0 153753 147761 147303 136311 6450 11450 0 0 -153753 -147761 -783373 -777381 609614 609614 20006 20006 0 0 0 0 0 0 20006402 20006402 20006402 20006402 5992 5027 -5992 -5027 -5992 -5027 0 0 0.00 0.00 20006402 20006402 0 490 -5000 -5574 10992 10111 0 0 0 0 0 0 0 0 0 0 0 0 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name to Green Planet Bioengineering Co., Ltd. (&#147;Company&#148;) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries which was subsequently divested to One Bio, Corp (&#147;ONE&#148;) on April 14, 2010.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">In March 2012, the Company became a subsidiary of Global Fund Holdings Corp. (&#147;Global Funds&#148;) an Ontario, Canada Corporation.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The Company operates as a public organized shell corporation with the purpose to acquire or merge with an existing business operation.&#160;&#160;The Company's activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif"><i>Basis of Presentation</i></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (&#147;U.S. GAAP&#148;) and are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company&#146;s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif"><i>Use of Estimates</i></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported.&#160;&#160;Actual results could differ from those estimates.&#160;&#160;Significant items that require estimates were accruals of liabilities.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif"><i>Cash and cash equivalents</i></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents.&#160;Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif"><i>Earnings per share</i></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">Earnings per share is reported in accordance with FASB ASC Topic 260 &#147;<i>Earnings per Share</i>&#148; which requires dual presentation of basic earnings per share (&#147;EPS&#148;) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures.&#160;&#160;Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive.&#160;&#160;Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif"><i>Fair Value Measurements</i></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">FASB ASC Topic 820, &#147;<i>Fair Value Measurements and Disclosures</i>&#148; defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investment measured and reported at fair value are classified and disclosed in one of the following hierarchy:</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">Level 1&#160;&#160;-&#160;&#160;Quoted prices are available in active markets for identical investments as of the period reporting date.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;Level 3 - Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment.&#160;&#160;The inputs into the determination of fair value require significant management judgment or estimation.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif"><i>Recent Changes in Accounting Standards</i></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">A variety of proposed or otherwise potential accounting standards are currently under study by standard-setting organizations and various regulatory agencies. Because of the tentative and preliminary nature of these proposed standards, management has not determined whether implementation of such proposed standards would be material to the Company&#146;s financial statements.</font></p> <p style="margin: 0; font: 8pt Times New Roman, Times, Serif"><font style="font: 8pt Times New Roman, Times, Serif">The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company&#146;s ability to continue as a going concern is dependent on continued support from Global Funds, the majority stockholder</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The Company relies on a related company to advance funds to finance its operating expenses.&#160;&#160;The amounts advanced are interest-free, unsecured and are repayable upon demand.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">Preferred stock</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The Company is authorized under its Articles of Incorporation to issue 10,000,000 shares of Series A preferred stock with a par value of $0.001 per share. Each share of the Company&#146;s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company&#146;s common stock. The preferred stock is non-participating and carries no dividend.</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">Common stock</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><font style="font: 8pt Times New Roman, Times, Serif">&#160;</font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><font style="font: 8pt Times New Roman, Times, Serif">The Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001 per share. During the three months ended March 31, 2016, the Company did not issue any shares of common stock or warrants.</font></p> <p style="margin: 0; font: 8pt Times New Roman, Times, Serif"><font style="font: 8pt Times New Roman, Times, Serif">There was no non-cash stock-based compensation recognized for the <font style="background-color: white">three months ended March 31, 2016 and 2015.</font></font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (&#147;U.S. GAAP&#148;) and are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company&#146;s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported.&#160;&#160;Actual results could differ from those estimates.&#160;&#160;Significant items that require estimates were accruals of liabilities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents.&#160;Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">Earnings per share is reported in accordance with FASB ASC Topic 260 &#147;<i>Earnings per Share</i>&#148; which requires dual presentation of basic earnings per share (&#147;EPS&#148;) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures.&#160;&#160;Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive.&#160;&#160;Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">FASB ASC Topic 820, &#147;<i>Fair Value Measurements and Disclosures</i>&#148; defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investment measured and reported at fair value are classified and disclosed in one of the following hierarchy:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Level 1&#160;&#160;-&#160;&#160;Quoted prices are available in active markets for identical investments as of the period reporting date.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;Level 3 - Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment.&#160;&#160;The inputs into the determination of fair value require significant management judgment or estimation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">A variety of proposed or otherwise potential accounting standards are currently under study by standard-setting organizations and various regulatory agencies. Because of the tentative and preliminary nature of these proposed standards, management has not determined whether implementation of such proposed standards would be material to the Company&#146;s financial statements.</p> Less than $.01, per share EX-101.SCH 5 gplb-20160331.xsd 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - 1. General Information link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - 2. Summary of significant accounting policies link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - 3. Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - 4. Amount Due to a Related Company link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - 5. Preferred stock / Common stock link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - 6. Stock-based compensation link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - 2. Summary of significant accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - 1. Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - 5. Preferred stock / Common stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 gplb-20160331_cal.xml EX-101.DEF 7 gplb-20160331_def.xml EX-101.LAB 8 gplb-20160331_lab.xml As Originally Reported Award Type [Axis] As Restated Preferred Stock Equity Components [Axis] Common Stock Additional Paid-In Capital Retained Earnings / Accumulated Deficit Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents TOTAL CURRENT ASSETS / TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIT LIABILITIES Current liabilities Accounts payable Accrued liabilities Amount due to a related party TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES STOCKHOLDERS' EQUITY Preferred stock: par value of $0.001 per share Authorized: 10,000,000 shares at March 31, 2016 and December 31, 2015 Issued and outstanding: 0 shares at March 31, 2016 and December 31, 2015 Common stock: par value of $0.001 per share Authorized: 250,000,000 shares at March 31, 2016 and December 31, 2015 Issued and outstanding: 20,006,402 shares at March 31, 2016 and December 31, 2015 Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS' DEFICIT TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT STOCKHOLDERS' DEFICIT Preferred stock, par value Preferred stock, authorized shares Preferred stock, issued shares Preferred stock, outstanding shares Common stock, par value Common stock, Authorized Common stock, Issued Common stock, outstanding Income Statement [Abstract] Administrative expenses Loss before taxes Provision for income taxes Net loss Earnings per share Basic and diluted Weighted average number of shares outstanding : Basic and diluted Statement of Cash Flows [Abstract] Cash flows from operating activities Net loss Changes in operating assets and liabilities : Accounts payable Accrued liabilities Amount due to a related party Net cash flows used by operating activities Cash flows from investing activities Cash flows from financing activities Net decrease in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Supplemental disclosures for cash flow information: Cash paid for interest Cash paid for Income taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] 1. General Information Notes to Financial Statements 2. Summary of significant accounting policies Text Block [Abstract] 3. Going Concern 4. Amount Due to a Related Company Equity [Abstract] 5. Preferred stock / Common stock Disclosure of Compensation Related Costs, Share-based Payments [Abstract] 6. Stock-based compensation Basis of Presentation Use of estimates Cash and cash equivalents Earnings per share Income Taxes Fair Value Measurements Recent Changes in Accounting Standards Reclassifications State of incorporation Incorporation Date Preferred stock par value Assets, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity General and Administrative Expense Income (Loss) from Continuing Operations before Income Taxes, Domestic Income Tax Expense (Benefit) Weighted Average Number of Shares Outstanding, Basic and Diluted Increase (Decrease) in Accounts Payable Increase (Decrease) in Other Accounts Payable Increase (Decrease) in Due to Related Parties Net Cash Provided by (Used in) Operating Activities Cash and Cash Equivalents, Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] EX-101.PRE 9 gplb-20160331_pre.xml XML 10 R1.htm IDEA: XBRL DOCUMENT v3.4.0.3
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2016
May. 13, 2016
Document And Entity Information    
Entity Registrant Name Green Planet Bio Engineering Co. Ltd.  
Entity Central Index Key 0001392449  
Document Type 10-Q  
Document Period End Date Mar. 31, 2016  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   20,006,402
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2016  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.4.0.3
Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 0 $ 0
TOTAL CURRENT ASSETS / TOTAL ASSETS 0 0
Current liabilities    
Accounts payable 0 0
Accrued liabilities 6,450 11,450
Amount due to a related party 147,303 136,311
TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES 153,753 147,761
STOCKHOLDERS' EQUITY    
Preferred stock: par value of $0.001 per share Authorized: 10,000,000 shares at March 31, 2016 and December 31, 2015 Issued and outstanding: 0 shares at March 31, 2016 and December 31, 2015 0 0
Common stock: par value of $0.001 per share Authorized: 250,000,000 shares at March 31, 2016 and December 31, 2015 Issued and outstanding: 20,006,402 shares at March 31, 2016 and December 31, 2015 20,006 20,006
Additional paid-in capital 609,614 609,614
Accumulated deficit (783,373) (777,381)
TOTAL STOCKHOLDERS' DEFICIT (153,753) (147,761)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 0 $ 0
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2016
Dec. 31, 2015
STOCKHOLDERS' DEFICIT    
Preferred stock, par value $ .001 $ .001
Preferred stock, authorized shares 10,000,000 10,000,000
Preferred stock, issued shares 0 0
Preferred stock, outstanding shares 0 0
Common stock, par value $ .001 $ .001
Common stock, Authorized 250,000,000 250,000,000
Common stock, Issued 20,006,402 20,006,402
Common stock, outstanding 20,006,402 20,006,402
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.4.0.3
Statements of Income (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Income Statement [Abstract]    
Administrative expenses $ (5,992) $ (5,027)
Loss before taxes (5,992) (5,027)
Provision for income taxes 0 0
Net loss $ (5,992) $ (5,027)
Earnings per share    
Basic and diluted [1] $ 0.00 $ 0.00
Weighted average number of shares outstanding :    
Basic and diluted 20,006,402 20,006,402
[1] Less than $.01, per share
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities    
Net loss $ (5,992) $ (5,027)
Changes in operating assets and liabilities :    
Accounts payable 0 490
Accrued liabilities (5,000) (5,574)
Amount due to a related party 10,992 10,111
Net cash flows used by operating activities 0 0
Cash flows from investing activities 0 0
Cash flows from financing activities 0 0
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents - beginning of period 0 0
Cash and cash equivalents - end of period 0 0
Supplemental disclosures for cash flow information:    
Cash paid for interest 0 0
Cash paid for Income taxes $ 0 $ 0
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
1. General Information
3 Months Ended
Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
1. General Information

Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name to Green Planet Bioengineering Co., Ltd. (“Company”) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries which was subsequently divested to One Bio, Corp (“ONE”) on April 14, 2010.

 

In March 2012, the Company became a subsidiary of Global Fund Holdings Corp. (“Global Funds”) an Ontario, Canada Corporation.

 

The Company operates as a public organized shell corporation with the purpose to acquire or merge with an existing business operation.  The Company's activities are subject to significant risks and uncertainties, as their ability to implement and execute future business plans and generate sufficient business revenue is directly influenced by their ability to secure adequate financing or find profitable business opportunities.

XML 16 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
2. Summary of significant accounting policies
3 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
2. Summary of significant accounting policies

Basis of Presentation

 

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.

 

Use of Estimates

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported.  Actual results could differ from those estimates.  Significant items that require estimates were accruals of liabilities.

 

Cash and cash equivalents

 

Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.

 

Earnings per share

 

Earnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures.  Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive.  Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share.

 

Fair Value Measurements

 

FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investment measured and reported at fair value are classified and disclosed in one of the following hierarchy:

 

Level 1  -  Quoted prices are available in active markets for identical investments as of the period reporting date.

Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

 Level 3 - Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment.  The inputs into the determination of fair value require significant management judgment or estimation.

 

Recent Changes in Accounting Standards

 

A variety of proposed or otherwise potential accounting standards are currently under study by standard-setting organizations and various regulatory agencies. Because of the tentative and preliminary nature of these proposed standards, management has not determined whether implementation of such proposed standards would be material to the Company’s financial statements.

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.4.0.3
3. Going Concern
3 Months Ended
Mar. 31, 2016
Text Block [Abstract]  
3. Going Concern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized shell corporation and has no current business activity. The Company’s ability to continue as a going concern is dependent on continued support from Global Funds, the majority stockholder

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
4. Amount Due to a Related Company
3 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
4. Amount Due to a Related Company

The Company relies on a related company to advance funds to finance its operating expenses.  The amounts advanced are interest-free, unsecured and are repayable upon demand.

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.4.0.3
5. Preferred stock / Common stock
3 Months Ended
Mar. 31, 2016
Equity [Abstract]  
5. Preferred stock / Common stock

Preferred stock

 

The Company is authorized under its Articles of Incorporation to issue 10,000,000 shares of Series A preferred stock with a par value of $0.001 per share. Each share of the Company’s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company’s common stock. The preferred stock is non-participating and carries no dividend.

 

Common stock

 

The Company is authorized to issue 250,000,000 shares of common stock with a par value of $0.001 per share. During the three months ended March 31, 2016, the Company did not issue any shares of common stock or warrants.

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
6. Stock-based compensation
3 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
6. Stock-based compensation

There was no non-cash stock-based compensation recognized for the three months ended March 31, 2016 and 2015.

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.4.0.3
2. Summary of significant accounting policies (Policies)
3 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
Basis of Presentation

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the fiscal period end. The results of operations for the fiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.

Use of estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses for the years reported.  Actual results could differ from those estimates.  Significant items that require estimates were accruals of liabilities.

Cash and cash equivalents

Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents. Balances of cash and cash equivalents in financial institutions may at times exceed the government-insured limits.

Earnings per share

Earnings per share is reported in accordance with FASB ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings, for all entities with complex capital structures.  Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive.  Fully diluted EPS is not provided, when the effect is anti-dilutive. When the effect of dilution on loss per share is anti-dilutive, diluted loss per share equals the loss per share.

Fair Value Measurements

FASB ASC Topic 820, “Fair Value Measurements and Disclosures” defines fair value, establishes a framework for measuring fair value in accordance with U.S. GAAP, and expands disclosures about fair value measurements. Investment measured and reported at fair value are classified and disclosed in one of the following hierarchy:

 

Level 1  -  Quoted prices are available in active markets for identical investments as of the period reporting date.

Level 2 - Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date, and fair value is determined through the use of models or other valuation methodologies.

 Level 3 - Pricing inputs are unobservable for the investment and included situations where there is little, if any, market activity for the investment.  The inputs into the determination of fair value require significant management judgment or estimation.

Recent Changes in Accounting Standards

A variety of proposed or otherwise potential accounting standards are currently under study by standard-setting organizations and various regulatory agencies. Because of the tentative and preliminary nature of these proposed standards, management has not determined whether implementation of such proposed standards would be material to the Company’s financial statements.

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.4.0.3
1. Organization (Details Narrative)
3 Months Ended
Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
State of incorporation Delaware
Incorporation Date Oct. 30, 2006
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.4.0.3
5. Preferred stock / Common stock (Details Narrative) - $ / shares
Mar. 31, 2016
Dec. 31, 2015
Notes to Financial Statements    
Preferred stock par value $ .001 $ .001
Preferred stock, authorized shares 10,000,000 10,000,000
Common stock, par value $ .001 $ .001
Common stock, Authorized 250,000,000 250,000,000
EXCEL 24 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( "2*K4BG&,& < $ -<+ 3 6T-O;G1E;G1?5'EP97-= M+GAM;,U6RV[",!#\%91K14QH2Q\"+J77%JG] =?9$ N_M#8!_KYV@*J-4@0M MD7R)X\SNS-AKKS)^WQJPO8T4RDZ2TCGS2(AE)4AJ4VU >:30**GS4UP00]F2 M+H ,!X,185HY4*[O DM2,R%,VHQ8^, M,/_C6AJ;6$DQ0[KF#8&JLS*%,964J[92K34N/[1>7O*80%A5#GG?H ]$QUM. MB0^>>]023_TO[<-)81KA),$0V.&E*"E"_N;0U[?];GP/Z,Y'J&O]_EO1:]"2 M>NBP29SE8QB)C^M(?-Q$XN,V$A^C2'S<1>+C/A(?#Y'XR :Q&(FEHV:QM-0L MEIZ:?3554O_/3S\!4$L#!!0 ( "2*K4A(=07NQ0 "L" + 7W)E M;',O+G)E;'.MDLMNPD ,17\EFGUQ2B46$6'%AAU"_( [XSR4S'CD,2+]^X[8 M@,)#K<32KWN/KKP.J:P.-*+V'%+7QU1,?@RIROW:=*JQ DBV(X]IP9%"GC8L M'C67TD)$.V!+L"S+%4EK0VTPAGEN&;>5ADZ3SX MB?078VZ:WM*6[13@2=&AXD7U(V8# M$NTIO8+Z>@"%,;X[)9J4@B,WHX*[O]C\ E!+ P04 " DBJU(&)@@)14! M '"@ &@ 'AL+U]R96QS+W=O'&6-#AM#5N4CX\NHY;5=]5!SP7 MHN!N.8==SC]G9[>F8N[62):]*->!K]B;<7?L 3SR^28W84$X?ECXSWK3MD,- M5U._3J#]'PK^M8#Q."B/@W(2T#8.VI* =G'0C@2TCX/V)* B#BI(0(#;K#M37?AB=%BVJC?XRP/F6>FC0L0NW#)N#S=?5O:Y[Z">&__ODN'U!+ M P04 " DBJU(-G-;7#<" 4!@ $ &1O8U!R;W!S+V%P<"YX;6R] M54UOVS ,_2N$3]NA<9)E/02I@2[I/H!M#9:V.PZ<3,="9C7J2L*K6CA5%.1Y70\')ZF=,=D<\I/ZCUIDLUBE_.Z-EHA:V>S3UIY M%US!<'&GR,S2QX"V0IA7I!JO>9L-.TP_U6)6"@W-I5=6H G4H7XE6\S<537: M;=J=/FI[&Z[K*[= IG[5X8>.O41/N30]8-\G6\S[K>@TL79>HEU3WL?^_G'G MQ0WY$)6.QH.A_/86[/(=-V&N[7J)VH=LMN'IAA0[_S"F#3]W2KE3<>CAYDKN M%Q+XCH%B>)9LT&NTG$#0]W(<)UW;+MO&I@[LLZ_.WX:2B,,LW2?;L(_MQWJ2 MC28M0J)#9+I7ECW8=J [9JXT&PJ7Q1(]_RH,&K2)8M:[!BVN+3:Z9\I=/@HMP:5@2RXJ8XR4KEH<;KQ7 M%7(?Y2KJ]7E"S1Q#"6^-^[&[W]&:T0#>D26/YJ^BQP-8-56%?AOI@UY;+2/ MZ)Q2KCE:\TKHG4P?YDX,\,>))P,XKUPC1(N&@!T@?"$C6G*(ZWZTYO4 EIX* M\K*^$-BI6_@6T96S\7BTYE0$1.1)?!^1_U_*P9_VE[&_7HUU*#_\#LI]02P,$% @ )(JM2->N*1L^ M 0 :0, !$ !D;V-0D'JH:_^??]=)(5TNK8N)25DHF4L/ JWO\$KV>+?W%<&49%!!#08#XQ/.DO+%[(QM3,$&?5E$ MQY4(N+1*KS6HVW8H^YV*G1%\'4YR4'U[^OJG!\JPI*L\!-U7-4TS:694%P?F M[&WY^$S_)M4FH# 2HBKH'%L'B^3<^75V=[]Z2,IIQN=I=IWRV8K?Y/')^/MQ ML@M_@^&Z&^+?.CX;I.VBQ@I&[I8TBI9+KP12$*37#K4UHW"$^28F6-A_?(+$ M\:!.2(=M!VUCO0HEG:\A.MZTI]2.ZN%7E%U!+ P04 " DBJU( MF5R<(Q & "<)P $P 'AL+W1H96UE+W1H96UE,2YX;6SM6EMSVC@4?N^O MT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\ M!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%#BVR]*+41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&& M^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\ MW*.76!4!EQC?-*HU+,76>)7 \:V@S&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX M?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH,@H%\;D>/N5Z M> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY; MQ/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9==N0C MI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[ MY\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4 MX&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM M(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9KF4Q9Z;RWRT, M"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[ M2$R<><41 71% B.5' 86%S+D4.Z2D 83 >LX=S MFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F M6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS< M_N\-L,+$CN'MB[\!4$L#!!0 ( "2*K4B,+(AM) ( /$' - >&PO MO5JOP[OSJ%#]S"^<8>8Z/!3!N+G&0QL&0*(U+ M):=\:^R!-&[OT9YP\(^L>ZZXTLA 0=2* D020;W'->$LT\R")1&,'SR\MH#; M@\%/,*FTR^TSG.:Y"*=,NLH2' [?T]-E$[L;;'F,\V5Y *1Q0XRA6FYA@@9[ M=VB@.*DD]2*=WR/>E2:':'TY"W #Y,V4+JA>'*2'TIC3TD" 9E5M1Z,:*UT9 MHP08!2.5DH1;RF/$8 !M3CF_M3?N:[G@[DOD?>P9AQA9%4<3-F(PIVO@-C68 MLWGN&>W;9]&BOASY(9HT#3]\X*R2@GJM'MJJ8?88??0 ?1J3(RNJE6;WX&_O M00X U1CMJ38LGR/?-6EVM#?#!0[Z\B&%SRWY3VKZ_;LVJ8$;^+>WYY\FGY^- M^POQB9XG',5-)S*JMZXI_[RPUV_^5V7V??@U:<'01V;-:M&J1A1E'>.&R:,& M8A^7&ZN;+]K(U*: L^BG#N56#&PO=V]R:V)O;VLN>&ULC93;4MLP$(9?1:,K>M$D-DZ #&:F$*#,M, 0 M2B\[&WL=:]#!(\D$\O1=.:2(FD*O[)6TG_;P:P_==&7L_<*8>_:HI'93F_/: M^V8Z'+JB1@5N8!K4M%<9J\"3:9=#4U6BP)DI6H7:#]/1:#*T*,$+HUTM&L>? M:>Y_:*ZQ"*6K$;V2&Y@"H?G1H9M60N(=6D=@!DUS"0IS_B@YD^#\:2D\ECG/ MR#0K?+5@V^:X%3(8X]&8#P-LF^JU984I<0.[K87[^;S!68D5M-+?4K#;>W.> MI%F:3C:,<.Q.X,K%P+# H/#B 6]AD?,19]!Z?M,\ M*DV(@0Y?E-W%=BKHQUZ4R:94,>@8).@"69>!8SL_-+1=LSY%C#1BI!\SKL%2 M:#5V!8@YNQ%GM\^9>^I(R,HQ4U$ZA5$8112!L@B4?00Z 5>S,Q+B-KT(-(Y MXSXH&;!SU&A!_J.ZD\A_TO=/!VS>*@7V*03BQ%(+>J 0^E84IHU >Q%HKP_: MI4 ,Z92=&*JTC4/8CSSW^Y[9@'U1IJ4K9RTR;QBPFS 1L"26:B+0000ZZ(/& M W9ML4)KR=5Y4]RS7P&A: *0&4MN%&MNU$=-J"P!\'D!CF#49QH^KJ?<5])] M0[OO5C=)8U2LX.0-"5.CK^P2M%AW4;"=&7H0TK%+L!9\C(I%G+RAXG?KE&0Q M*I9QDCV__I<'3S-/:"S#.'3=-?2YF?,PW&B.M5*> MT-J5_F:@&P$;\G8J'OT&4$L#!!0 ( "2*K4@]/:!890( , ( 8 M>&PO=V]R:W-H965T&UL?5;;CILP$/T5Q 9P/C[Z*B5'H?;=.)@U]) MV>^#0!05;8EX83WMU,J5\99(->2W0/2]L2_N=$&S8"9$V_\2HHD0S004&T_'G1F_OA!)\HRSP>/C MS^B)_N=H'ZF3*_2D.2BSICP3:O:1AUGPT&8FQ&E$X 4"S8A V9X%,"1PP@X= M_RMP=A$1+!"!'D2&'BWH,4R/07ILZ/&"GE@'X")26" !!1*'OK$$1D1J$-UX MPM$.Q_$.EDE!F=21V5HR+F)%8 ,*;!PZLD,%@*S$RA:4V+I\*UA. &0E6G:@ MQ,[EQY8$ $E@"7U!0#D5NA92.ZL S&9%925SD6O!_N409DT%3-\CPJZ%G:WB M8G"XH@+G,(I<"\A6 3!X105.=>1F,HZLRVC"+)-1E;PPC<,U+3CKD9OVV ZT M"9,L,6N1!B<]S,[%^HA-P?F$ MYUE/;O0'X;>Z$]Z%256V3'&Y,B:IVDSXHIRMU'-B'C3T*G5WH_I\++#C0++^ M^5Z8'RWY7U!+ P04 " DBJU(.%"IV8\" T"@ & 'AL+W=O?=SO/8L20- M9D^T(ZUX/=3W!)V5J:B_P_=AK<-6Z>:;&7OH\HU=>5RUYZ1UV M;1K<_WLF-1WV+G!O Z_5I>1RP,LS;_:=JH:TK**MTY/SWOT*=@6(I40I?E=D M8(NV(^$/E+[)SL_3WO4E ZG)D24'J6D82,_^=@G[.*8W+]BWZ=Y6N MP#]@1@I:_ZE.O!2TONNP_@F\2>;W1!,AF V@'#3 "<#U S>2*;R^H8YSK.>#DX__AD=EO\YV$&Q MXGSO\(7\POVE:IES MH%Q<%=2!?J:4$Q'.?Q+)E>(*-W=J>CP2T[N17GW1$ EE>H@>R%=*@55TI"&\C% MDMX ZRB"A3(U& 2>EX &UJV;I6KOE68IN7--)#^/2-,^I/KN\^- MM_I6<;D!LA1,OJ)N4,MJTCH4E2?WBW^\^)Z4*,6O&O5L-G"UG.= M I7PCOD;Z;^CL898!LP)9NK?R>^,D^9I<9T&?@QCW:JQ'ZY$T6BS&X+1$$P& M?]T0CH90,X"!3-7U%7*8I93T#AT>1@?E,_>/H;ASN=Q4-TI=$Y4QL?O(HB@% M#QEGE)P'23"3!$O%Q:+83Q(@\D\0@14B4/YP#A';_:'5'RI_-/Z9%(1/5>Q$=1B5-Q6F!4.:Z":,3O@K1\M#:4 M^#VE'VKS\[ Q;:6!E"03R@66KPM)25DJ3S+RW][I+:8BCM=7[]]UNE+^'G.2 MTO)/<1"Y5&N;QH$<\;D4[[3]0?H@(:""AX2'![@CL0!F$PP>L)WHW@Z=)TJ>A"[+# 2YKOC?FK20TZ2*@AM89\\Z-HF@B$LM&"%A_4 MXL^U1!,M'21XH@5"+6H)0"W!3$M@3[0$LR@3Q.X1XDY#"&H(YQJTQXR]#3B,[\.SIU7T%>:\*[$2O#AH\S"EP:W'RA3#3_F6- M^G%%V$D/-FYD]%P+11U9A^&Y1:J?3^RI&JJ 72:W3AV((?7)$SV'K5OH)&[P MB?S"[%34W-A3(2>,G@-'2@61:=DOLH/D\E=AV)3D*-0RE&O6#<]N(VAS_1<8 M?DB2_U!+ P04 " DBJU(U(QB"*<" "?"@ & 'AL+W=O>9&SBZS*AKYR3USJ MFO!_:UJQZ])'_FW@K3R>I!X(BCSH??NRIHTH6>-Q>ECZ*[38(*PE1O&GI%@JB+I]T0ZM*SZ0B?W23WF-JX_#^-OL/DZ[" MWQ)!-ZSZ6^[E2=&&OK>G!W*IY!N[_J1=#JF><,3K_9: M-N9Z;=^D46>##5%GB'I#'PJ1XB@".O(L4?C !M7 MD<[@"#&80VS\\3"'.>Q/0']B_,G0CZQOT$JPD31&\BW-,CL12!5&&&9)09;4 MS26#_3/0/W-RB6,KEU8R&U"&5AZN(LE"F *#%-BE2"P*[,10WRJT22!5BA.8 M90ZRS%V6U&*9.U%0Z*XNI$+HP5[(0);,8<%6QNOLZ>I,*48,NGY!6SYT*>S_ M>Z>9PIB4C#D>E![D,YUFDF-*,N: RQB*70Y[ MUW2:28XIR9@#+H?(K8?8WC&=9I)C2C+F@$LAUX. M)R5C#K@<(K<>XKG-@9W#P^&8DK0

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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 26 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 28 FilingSummary.xml IDEA: XBRL DOCUMENT 3.4.0.3 html 7 62 1 true 0 0 false 3 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://greenplanetbio.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets (Unaudited) Sheet http://greenplanetbio.com/role/BalanceSheets Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://greenplanetbio.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Income (Unaudited) Sheet http://greenplanetbio.com/role/StatementsOfIncome Statements of Income (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Cash Flows (Unaudited) Sheet http://greenplanetbio.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - 1. General Information Sheet http://greenplanetbio.com/role/GeneralInformation 1. General Information Notes 6 false false R7.htm 00000007 - Disclosure - 2. Summary of significant accounting policies Sheet http://greenplanetbio.com/role/SummaryOfSignificantAccountingPolicies 2. Summary of significant accounting policies Notes 7 false false R8.htm 00000008 - Disclosure - 3. Going Concern Sheet http://greenplanetbio.com/role/GoingConcern 3. Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - 4. Amount Due to a Related Company Sheet http://greenplanetbio.com/role/AmountDueToRelatedCompany 4. Amount Due to a Related Company Notes 9 false false R10.htm 00000010 - Disclosure - 5. Preferred stock / Common stock Sheet http://greenplanetbio.com/role/PreferredStockCommonStock 5. Preferred stock / Common stock Notes 10 false false R11.htm 00000011 - Disclosure - 6. Stock-based compensation Sheet http://greenplanetbio.com/role/Stock-basedCompensation 6. Stock-based compensation Notes 11 false false R12.htm 00000012 - Disclosure - 2. Summary of significant accounting policies (Policies) Sheet http://greenplanetbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies 2. Summary of significant accounting policies (Policies) Policies 12 false false R13.htm 00000013 - Disclosure - 1. Organization (Details Narrative) Sheet http://greenplanetbio.com/role/OrganizationDetailsNarrative 1. Organization (Details Narrative) Details 13 false false R14.htm 00000014 - Disclosure - 5. Preferred stock / Common stock (Details Narrative) Sheet http://greenplanetbio.com/role/PreferredStockCommonStockDetailsNarrative 5. Preferred stock / Common stock (Details Narrative) Details http://greenplanetbio.com/role/PreferredStockCommonStock 14 false false All Reports Book All Reports gplb-20160331.xml gplb-20160331.xsd gplb-20160331_cal.xml gplb-20160331_def.xml gplb-20160331_lab.xml gplb-20160331_pre.xml true true ZIP 30 0001354488-16-007428-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001354488-16-007428-xbrl.zip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end